NEOGEN.BO(NEOGEN.BO)
NEOGEN.BO
No analyst ratings available
No analyst price targets available for NEOGEN.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $12.00B | $20.91B | $24.49B | $27.12B | $37.95B |
| Low | $9.72B | $17.70B | $20.42B | $22.61B | $31.64B |
| High | $12.81B | $22.66B | $26.41B | $29.24B | $40.92B |
| EBITDA Avg | $2.05B | $3.57B | $4.18B | $4.63B | $6.47B |
| Low | $1.66B | $3.02B | $3.48B | $3.86B | $5.40B |
| High | $2.19B | $3.87B | $4.51B | $4.99B | $6.98B |
| EBIT Avg | $1.69B | $2.95B | $3.45B | $3.82B | $5.35B |
| Low | $1.37B | $2.49B | $2.88B | $3.19B | $4.46B |
| High | $1.81B | $3.19B | $3.72B | $4.12B | $5.77B |
| Net Income Avg | $493M | $1.13B | $1.79B | $1.97B | $2.47B |
| Low | $367M | $985M | $888M | $1.54B | $1.94B |
| High | $654M | $1.27B | $2.02B | $2.16B | $2.72B |
| EPS Avg | $17.58 | $42.49 | $55.16 | $74.50 | $93.60 |
| Low | $13.93 | $37.35 | $33.65 | $58.40 | $73.37 |
| High | $24.78 | $48.06 | $76.67 | $82.08 | $103.12 |
| Analysts (Rev / EPS) | 9 / 5 | 9 / 6 | 4 / 2 | 3 / 1 | 2 / 1 |